A pharmacokinetic, pharmacodynamic and pharmacogenetic study of sorafenib (BAY-43-9006 Tosylate) and blood pressure elevation in patients with advanced malignancies
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 03 Feb 2006
At a glance
- Drugs Sorafenib (Primary)
- Indications Cancer
- Focus Pharmacodynamics; Pharmacogenomic
- 03 Feb 2006 New trial record.